Literature DB >> 10626858

Extensive surgery improves recurrence-free survival for children and young patients with class I papillary thyroid carcinoma.

C A Welch Dinauer1, R M Tuttle, D K Robie, D R McClellan, G L Francis.   

Abstract

BACKGROUND: Children with papillary thyroid cancer (PTC) rarely die of their disease, but are at high risk for recurrence, particularly with multifocal tumors (which occur in 42% of children with PTC). It is not clear if more extensive surgery, with an increased risk of complications, lessens the risk for recurrence. The authors hypothesized that patients with disease presumed to be confined to the thyroid gland (class I PTC) could have multifocal disease, involving the contralateral lobe, of which the surgeon is unaware. Treatment with less than subtotal thyroidectomy might be associated with a higher risk of recurrence.
METHODS: The charts of 37 patients with Class I PTC diagnosed at < or =21 years of age between 1953 and 1996 were reviewed. The incidence of surgical complications and the risk of recurrence based on the extent of initial surgery ([1] lobectomy with or without isthmusectomy, [2] subtotal, or [3] total thyroidectomy) and adjunctive therapy with thyroid hormone or radioactive iodine (RAI) were examined.
RESULTS: Eight patients had recurrent PTC. Patients treated with lobectomy with or without isthmusectomy were more likely to have recurrence than patients treated with subtotal or total thyroidectomy (Odds ratio, 8.7; 95% CI 1.4 to 54). Although the incidence of complications was statistically similar among the 3 surgical groups, 3 patients, all treated with more extensive surgery, had permanent hypoparathyroidism. There were too few patients to determine whether treatment with thyroid hormone or RAI offered additional benefit.
CONCLUSIONS: In children with Class I PTC, more extensive surgery is associated with a lower risk of recurrence. This finding must be weighed against the risk of complications when determining the optimal treatment for individual patients.

Entities:  

Mesh:

Year:  1999        PMID: 10626858     DOI: 10.1016/s0022-3468(99)90316-0

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

1.  Pediatric thyroid cancers: an Indian perspective.

Authors:  Devendra A Chaukar; Abhishek D Vaidya
Journal:  Indian J Surg Oncol       Date:  2012-02-16

Review 2.  The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.

Authors:  Scott A Rivkees; Ernest L Mazzaferri; Frederik A Verburg; Christoph Reiners; Markus Luster; Christopher K Breuer; Catherine A Dinauer; Robert Udelsman
Journal:  Endocr Rev       Date:  2011-08-31       Impact factor: 19.871

3.  Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.

Authors:  A M Straight; A Patel; C Fenton; C Dinauer; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

4.  Papillary Thyroid Carcinoma in Children and Adolescents: Long-Term Follow-Up and Clinical Characteristics.

Authors:  Kiminori Sugino; Mitsuji Nagahama; Wataru Kitagawa; Hiroshi Shibuya; Keiko Ohkuwa; Takashi Uruno; Akifumi Suzuki; Junko Akaishi; Chie Masaki; Ken-ichi Matsuzu; Koichi Ito
Journal:  World J Surg       Date:  2015-09       Impact factor: 3.352

5.  Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer.

Authors:  Francoise Borson-Chazot; Sylvain Causeret; Jean-Christophe Lifante; Marylin Augros; Nicole Berger; Jean-Louis Peix
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

Review 6.  Evaluation and management of the pediatric thyroid nodule.

Authors:  Jeremy T Guille; Adwoa Opoku-Boateng; Susan L Thibeault; Herbert Chen
Journal:  Oncologist       Date:  2014-12-05

Review 7.  The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: natural history, diagnosis, differential diagnosis and management.

Authors:  C A Koch; N J Sarlis
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 5.467

8.  Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline.

Authors:  Sasha R Howard; Sarah Freeston; Barney Harrison; Louise Izatt; Sonali Natu; Kate Newbold; Sabine Pomplun; Helen A Spoudeas; Sophie Wilne; Tom R Kurzawinski; Mark N Gaze
Journal:  Endocr Relat Cancer       Date:  2022-09-07       Impact factor: 5.900

9.  Differentiated thyroid carcinoma of children and adolescents: 27-year experience in the yonsei university health system.

Authors:  Seulkee Park; Jun Soo Jeong; Haeng Rang Ryu; Cho-Rok Lee; Jae Hyun Park; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  J Korean Med Sci       Date:  2013-05-02       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.